Browsing Tag
Evofem Biosciences
2 posts
Aditxt eyes Pearsanta IPO and oncology pivot as ADTX (NASDAQ) tests retail patience
Aditxt regained Nasdaq compliance, then filed to issue 148 million shares. ADTX retail investors are watching Pearsanta's IPO and a bitXbio crypto pivot.
May 2, 2026
Big pharma shakeup: Lupin sells women’s health arm for mega millions
Lupin Limited, a global pharmaceutical leader, has officially divested its U.S. Commercial Women’s Health Specialty Business to Evofem…
July 15, 2024